ARCHIVES

Switching to Tasigna After Gleevec Therapy Can Achieve Deeper Molecular Response

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Phase III Lung and Pancreatic Cancer Trials Are Stopped

April 30, 2010

NCI To Pilot Text Chat On CancerNet And CIS Sites.

September 29, 2000

RFPs Available, NIH Funding Strategies

February 18, 1994

NCI CTEP-Approved Trials For the Month of March

March 28, 2014

Lawyer Says Salick didn’t Anticipate Ouster By Zeneza

May 2, 1997

In Brief: Krakoff To Head New M.D. Anderson Division, Two Other Appointments Made In Reorganization There

July 22, 1983